(19)
(11) EP 1 229 793 A1

(12)

(43) Date of publication:
14.08.2002 Bulletin 2002/33

(21) Application number: 00983722.0

(22) Date of filing: 17.11.2000
(51) International Patent Classification (IPC)7A01N 61/00, A61K 38/00, A61K 38/43, C12N 11/00, C12N 11/02, C07K 1/00, C07K 17/00, C07K 17/02, C07K 17/06
(86) International application number:
PCT/US0031/701
(87) International publication number:
WO 0135/748 (25.05.2001 Gazette 2001/21)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 19.11.1999 US 166633 P

(71) Applicant: THE BOARD OF TRUSTEES OFTHE LELAND STANFORD JUNIOR UNIVERSITY
Palo Alto, CA 94304-1850 (US)

(72) Inventors:
  • BRIESEWITZ, Roger
    Mountain View, CA 94040 (US)
  • CRABTREE, Gerald, R.
    Woodside, CA 94062 (US)
  • WANDLESS, Thomas
    Menlo Park, CA 94025 (US)

(74) Representative: Brasnett, Adrian Hugh et al
Mewburn EllisYork House23 Kingsway
London WC2B 6HP
London WC2B 6HP (GB)

   


(54) BIFUNCTIONAL MOLECULES HAVING MODULATED PHARMACOKINETIC PROPERTIES AND THERAPIES BASED THEREON